Compare VSECU & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VSECU | ENOV |
|---|---|---|
| Founded | N/A | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Fluid Controls |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1995 | 2008 |
| Metric | VSECU | ENOV |
|---|---|---|
| Price | $58.15 | $26.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $47.38 |
| AVG Volume (30 Days) | 6.1K | ★ 1.2M |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.94 | N/A |
| Revenue | ★ $760,113,000.00 | N/A |
| Revenue This Year | N/A | $6.36 |
| Revenue Next Year | N/A | $5.31 |
| P/E Ratio | $28.68 | ★ N/A |
| Revenue Growth | ★ 9.88 | N/A |
| 52 Week Low | $38.45 | $19.14 |
| 52 Week High | $68.10 | $34.28 |
| Indicator | VSECU | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 48.27 | 50.10 |
| Support Level | $45.57 | $24.92 |
| Resistance Level | $58.54 | $27.51 |
| Average True Range (ATR) | 1.32 | 1.51 |
| MACD | -0.16 | -0.23 |
| Stochastic Oscillator | 17.62 | 34.14 |
VSE Corp is a diversified aftermarket products and services company serving commercial and government markets. The Company's operations include aircraft and airframe parts supply and distribution, and MRO services of aircraft components and engine accessories. The Company operates as a single reportable segment: Aviation, which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.